QURE stock news · uniQure
Get alerts for QURE
Follow uniQure (QURE) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for QUREFree on the App Store and Google Play, or on the web.
On Tuesday, 12 health care stocks saw big price changes during the day.
NeutraluniQure's shares fell 36.77% to $24.73, but the story gives no business reason. It reports no new company fact, so the outlook is unchanged.
What's causing uniQure's stock to drop on Tuesday?
NeutraluniQure reported strong 36-month results, but its 48-month findings were less clear. The results point in different directions, so they do not yet change the outlook for the company.
uniQure N.V. shares news about its AMT-130 clinical trials.
NeutraluniQure disclosed an update to its AMT-130 clinical trials, but the filing gives no trial results. It does not change what we can say about the company’s prospects.
12 health care stocks are changing a lot before the market opens on Tuesday.
NeutraluniQure was listed among pre-market decliners. The article gives no company news explaining the move, so it does not change the view of its business.